POLYTHERAPIES

• 收藏
• 分享

专利权人:

INC.;SYNDAX PHARMACEUTICALS

发明人:

ORDENTLICH, PETER,WANG, LEI

申请号：

CA3063718

公开号：

CA3063718A1

申请日:

2018.05.18

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The present disclosure relates to a combination of an anti-CSF-1R antibody or anti- CSF-1 antibody or antigen binding fragment thereof or an inhibitor of CSF-1R activity and an HDAC inhibitor, e.g., entinostat, and methods of using the combination for administering to subjects in need thereof for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/